Reported Q: Q3 2024 Rev YoY: -11.5% EPS YoY: -164.6% Move: +1.18%
China Risun Group Limited
1907.HK
HKD2.57 1.18%
Exchange HKSE Sector Basic Materials Industry Chemicals
Q3 2024
Published: Sep 30, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 1907.HK

Reported

Report Date

Sep 30, 2024

Quarter Q3 2024

Revenue

11.17B

YoY: -11.5%

EPS

-0.01

YoY: -164.6%

Market Move

+1.18%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $11.17B down 11.5% year-over-year
  • EPS of $-0.01 decreased by 164.6% from previous year
  • Gross margin of 7.3%
  • Net income of -45.86M
  • "N/A" - N/A
1907.HK
Company 1907.HK

Executive Summary

China Risun Group Long: QQ3 2024 (quarter ending 2024-09-30) delivered a revenue decline with continued margin pressure and a negative quarterly Net Income, highlighting the cyclicality and commodity-dependence of Risun’s coke and chemical business. Revenue fell 11.5% year-over-year and 11.4% quarter-over-quarter to 11.17 billion CNY, while gross profit was 817.46 million CNY for a gross margin of 7.32%. Despite EBITDA of 840.57 million CNY, the company reported a net loss of 45.86 million CNY, reflecting high depreciation, other expenses, and working-capital dynamics that weighed on reported profitability.

From a liquidity and balance-sheet perspective, Risun remains heavily levered with total debt of 30.38 billion CNY and net debt of 28.29 billion CNY. The current ratio stands at 0.62, underscoring near-term liquidity pressures, even as operating cash flow was positive at 237.21 million CNY. Free cash flow generated in the period was 845.29 million CNY, but a sizable negative net change in cash (βˆ’3.64 billion CNY) reflects significant working-capital movements and other non-operating outflows. The firm’s capital allocation appears anchored by a continued emphasis on asset base maintenance and potential deleveraging, though no formal quarterly guidance was disclosed.

Looking ahead, the near-term investment thesis is cautious: the business remains exposed to cyclical demand in steel and chemicals, commodity-price volatility, and high leverage. A meaningful improvement will depend on deleveraging progress, stabilization of input costs, and a sustained recovery in steel-driven downstream demand. Investors should monitor debt maturity profiles, working-capital efficiency, and any management commentary on cost-reduction initiatives or asset-light strategies at the operating level.

Key Performance Indicators

Revenue
Decreasing
11.17B
QoQ: -11.40% | YoY: -11.50%
Gross Profit
Decreasing
817.46M
7.32% margin
QoQ: -11.85% | YoY: -10.76%
Operating Income
Decreasing
321.66M
QoQ: -16.52% | YoY: -20.00%
Net Income
Decreasing
-45.86M
QoQ: -182.00% | YoY: -163.18%
EPS
Decreasing
-0.01
QoQ: -183.46% | YoY: -164.63%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 20,548.61 0.01 +84.0% View
Q1 2025 10,274.31 0.00 -18.5% View
Q4 2024 11,166.99 -0.01 -11.5% View
Q3 2024 11,166.99 -0.01 -11.5% View